Approval · Notice of Compliance 20814 · 2018
DONEPEZIL: Notice of Compliance 20814
Issued May 2, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20814
- Date
- May 2, 2018
- Company
- Laboratoire Riva Inc.Blainville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies
- Canadian reference product
- ARICEPT (Pfizer Canada Ulc)
Products in this notice
Medicinal ingredients
- DONEPEZIL HYDROCHLORIDE 10 MG per TAB
- DONEPEZIL HYDROCHLORIDE 5 MG per TAB